There are four types of asthma classified by severity: mild intermittent, mild persistent, moderate persistent, and severe persistent. Treatment options range from short-acting beta agonists as needed for mild intermittent asthma up to high dose inhaled corticosteroids and oral prednisone for severe persistent asthma. Asthma is diagnosed through pulmonary function tests, nocturnal peak flow measurements, or response to inhaled glucocorticoid treatment over 2-4 weeks.
There are four types of asthma classified by severity: mild intermittent, mild persistent, moderate persistent, and severe persistent. Treatment options range from short-acting beta agonists as needed for mild intermittent asthma up to high dose inhaled corticosteroids and oral prednisone for severe persistent asthma. Asthma is diagnosed through pulmonary function tests, nocturnal peak flow measurements, or response to inhaled glucocorticoid treatment over 2-4 weeks.
There are four types of asthma classified by severity: mild intermittent, mild persistent, moderate persistent, and severe persistent. Treatment options range from short-acting beta agonists as needed for mild intermittent asthma up to high dose inhaled corticosteroids and oral prednisone for severe persistent asthma. Asthma is diagnosed through pulmonary function tests, nocturnal peak flow measurements, or response to inhaled glucocorticoid treatment over 2-4 weeks.
- There are four types of asthma based on severity Mild intermittent - Symptoms </= 2 days/week, nighttime awakenings </= 2x/month, use of beta agonist </=2 times/week, FEV1 and FEV1/FVC normal, no limitations on daily activities - Rx: short acting beta agonist (eg albuterol) as needed (PRN), no need of daily controller meds Mild persistent - Symptoms >2 days/week but less than daily, nighttime awakenings 3-4x/month, FEV1 and FEV1/FVC normal, mild limitations of daily activities - Rx: short acting beta agonist (eg albuterol) as needed (PRN), low dose inhaled corticosteroids as controller med Moderate persistent - Symptoms daily, nighttime awakenings weekly, FEV1 60-80% predicted - Rx: short acting beta agonist (eg albuterol) as needed (PRN) + low dose inhaled corticosteroids+ long acting beta 2 agonists inhaler Severe persistent - Symptoms throughout day, frequent nighttime awakenings, FEV1 <60% predicted, extremely limited activities - Rx: short acting beta agonist (eg albuterol) as needed (PRN) + long acting beta 2 inhaler+ high dose inhaled corticosteroids. Oral prednisone can also be used in cases of severe persistent asthma Diagnosis of asthma - PFTs/spirometry to assess bronchodilator responseno responsemethacoline challenge test - Nocturnal or early morning peak expiratory flow rates measurement—for those with nocturnal symptoms only - Alternative approach: 2-4 wks treatment with inhaled glucocorticoidsimproved conditionasthma diagnosed